Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Clague Laura

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
TVTXTravere Therapeutics, Inc.Clague LauraChief Financial OfficerMay 10, 2022Sale$21.5182517,74637,030May 12, 2022, 08:45 PM
TVTXTravere Therapeutics, Inc.Clague LauraChief Financial OfficerMay 11, 2022Sale$21.511,37529,57635,655May 12, 2022, 08:45 PM
GNSSGenasys Inc.Clague LauraDirectorApr 27, 2022Option Exercise$1.3350,00066,500284,311Apr 27, 2022, 07:02 PM
GNSSGenasys Inc.Clague LauraDirectorFeb 23, 2022Option Exercise$2.5633,71686,268218,027Feb 24, 2022, 01:54 PM
TVTXTravere Therapeutics, Inc.Clague LauraChief Financial OfficerJan 31, 2022Sale$27.401,23833,92137,855Feb 02, 2022, 04:17 PM
TVTXTravere Therapeutics, Inc.Clague LauraChief Financial OfficerJan 24, 2022Sale$24.982,06351,53429,253Jan 26, 2022, 04:34 PM
TVTXTravere Therapeutics, Inc.Clague LauraChief Financial OfficerJan 11, 2022Sale$27.407,500205,50031,316Jan 12, 2022, 04:05 PM
TVTXTravere Therapeutics, Inc.Clague LauraChief Financial OfficerAug 17, 2021Sale$17.121,40724,08531,316Aug 17, 2021, 07:34 PM
GNSSGenasys Inc.Clague LauraDirectorMar 10, 2021Option Exercise$3.1825,45680,865175,600Mar 12, 2021, 12:43 PM
TVTXTravere Therapeutics, Inc.Clague LauraChief Financial OfficerFeb 05, 2021Sale$31.412,25070,67234,473Feb 09, 2021, 04:29 PM
TVTXTravere Therapeutics, Inc.Clague LauraChief Financial OfficerFeb 08, 2021Sale$31.582,25071,05532,223Feb 09, 2021, 04:29 PM
TVTXTravere Therapeutics, Inc.Clague LauraChief Financial OfficerFeb 03, 2021Sale$28.913,625104,79933,348Feb 03, 2021, 09:30 PM
TVTXTravere Therapeutics, Inc.Clague LauraChief Financial OfficerFeb 02, 2021Sale$30.753,625111,46936,973Feb 02, 2021, 09:19 PM
RTRXTravere Therapeutics, Inc.Clague LauraChief Financial OfficerNov 24, 2020Sale$23.863,75089,47523,223Nov 25, 2020, 07:00 PM
RTRXTravere Therapeutics, Inc.Clague LauraChief Financial OfficerNov 25, 2020Sale$22.723,75085,20019,473Nov 25, 2020, 07:00 PM
RTRXTravere Therapeutics, Inc.Clague LauraChief Financial OfficerNov 16, 2020Sale$23.987,500179,81319,473Nov 17, 2020, 09:00 PM
RTRXRetrophin, Inc.Clague LauraChief Financial OfficerNov 13, 2020Sale$23.617,500177,07126,973Nov 13, 2020, 09:24 PM
RTRXRetrophin, Inc.Clague LauraChief Financial OfficerSep 23, 2020Sale$18.481,50027,72019,473Sep 23, 2020, 08:00 PM
RTRXRetrophin, Inc.Clague LauraChief Financial OfficerSep 22, 2020Sale$18.591,50027,88520,973Sep 22, 2020, 09:18 PM
RTRXRetrophin, Inc.Clague LauraChief Financial OfficerMay 11, 2020Sale$14.951,25018,68721,250May 13, 2020, 09:00 PM
RTRXRetrophin, Inc.Clague LauraChief Financial OfficerMay 12, 2020Sale$17.111,77730,40120,000May 13, 2020, 09:00 PM
RTRXRetrophin, Inc.Clague LauraChief Financial OfficerMar 10, 2020Sale$15.024,00060,08022,500Mar 12, 2020, 07:43 PM
RTRXRetrophin, Inc.Clague LauraChief Financial OfficerMay 15, 2019Sale$17.781,25022,22514,750May 16, 2019, 09:37 PM
RTRXRetrophin, Inc.Clague LauraChief Financial OfficerMay 16, 2019Sale$18.711,25023,38713,500May 16, 2019, 09:37 PM
RTRXRetrophin, Inc.Clague LauraChief Financial OfficerFeb 11, 2019Sale$21.381,01721,74311,016Feb 13, 2019, 08:49 PM
RTRXRetrophin, Inc.Clague LauraChief Financial OfficerFeb 12, 2019Sale$21.501,01621,84410,000Feb 13, 2019, 08:49 PM
RTRXRetrophin, Inc.Clague LauraChief Financial OfficerDec 20, 2018Sale$22.083,75082,80415,783Dec 21, 2018, 08:19 PM
RTRXRetrophin, Inc.Clague LauraChief Financial OfficerDec 21, 2018Sale$21.833,75081,86012,933Dec 21, 2018, 08:19 PM
RTRXRetrophin, Inc.Clague LauraChief Financial OfficerNov 14, 2018Sale$23.733,75088,97016,183Nov 16, 2018, 07:16 PM
RTRXRetrophin, Inc.Clague LauraChief Financial OfficerNov 15, 2018Sale$24.313,75091,16712,824Nov 16, 2018, 07:16 PM
LRADLRAD CorpClague LauraDirectorSep 04, 2013Option Exercise$0.7339,40028,87632,000Sep 06, 2013, 04:45 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe